The Gut-Joint Axis: A New Target



Tue, Oct 11, 2022 12:00 PM EDT What is the Gut-Immune-Joint Relationship? Learn how to optimize ROI from Joint, Immunity, and Gut Health clinical trials.

Register Free:

Event Overview:

Learn how the gut-brain-immune axis is driving new clinical research in nutraceuticals! Emerging research is exploring the pathogenesis of several diseases affecting both the joint and immune systems, providing the molecular basis for novel therapeutic strategies. This comprehensive seminar will help you understand the interplay between joint health and the immune system and how it is associated with the gut microflora. Learn about proven strategies to help you optimally design your clinical trial. Experienced industrial experts will address the biomarkers involved in the joint-immune relationship and discuss the role of mediators of immune cells in regulating the chondrogenic activities in case of age-related degeneration of joints.

Key Learning:

  • Understand the different health claims linking the symptomatic assessment of joint health and immune health as well as gut microbiota to maximize the impact of an IP
  • Biomarkers and tools: Learn about gold standards for research on the gut-joint axis and immune-joint axis
  • Learn the key dos and don’ts of designing a joint-gut-immunity health study (including type of population, statistically drawn sample size, tools, and treatment period).
  • Learn how to use your gut and immunity product to promote a joint health study
  • Hear about current trending health studies from CT.GOV and other platforms and the health claims that form the basis and what can be built on that

Speakers Name and Title:

Anthony L. Almada, MSc, FISSN
President and CSO
IMAGINutrition, Inc.

Dr. Shalini Srivastava,
Associate Director Clinical Development,
Vedic Lifesciences

Times and Date:

Tue, Oct 11, 2022 12:00 PM EDT


Vedic Lifesciences

Register Free:

Related Content
© 2024 MJH Life Sciences

All rights reserved.